CORD-PICO  

CORD-19:bf39a81c9aab9e0569f33d93d5e203d320dac024 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
p1_all0 55-77 Outcome denotes severity and mortality
p2_o1 55-77 Mortality denotes severity and mortality
p1_all1 88-104 Intervention denotes medRxiv preprint
p2_i0 88-104 Educational denotes medRxiv preprint
p1_all2 264-281 Outcome denotes percentage of men
p1_all3 548-578 Intervention denotes Novel Coronavirus (SARS-CoV-2)
p1_all4 710-732 Outcome denotes severity and mortality
p1_all5 741-793 Population denotes male and female patients with both COVID-19 and SARS
p2_p0 951-953 Sample-size denotes 43
p1_all6 951-1111 Population denotes 43 hospitalized patients we treated, a public data set of the first 37 cases died of COVID-19 in Wuhan city and 1019 survived patients from six cities in China.
p2_i1 1036-1044 Pharmacological denotes COVID-19
p1_all7 1141-1219 Population denotes 524 patients with SARS, including 139 deaths, from Beijing city in early 2003.
p2_o8 1179-1185 Mortality denotes deaths
p1_all8 1220-1271 Outcome denotes Main Outcomes and Measures: Severity and mortality.
p2_o9 1261-1270 Mortality denotes mortality
p1_all9 1281-1323 Outcome denotes Older age and high number of comorbidities
p1_all10 1352-1374 Outcome denotes severity and mortality
p2_o10 1365-1374 Mortality denotes mortality
p1_all11 1420-1456 Outcome denotes percentages of older age (≥65 years)
p2_p1 1446-1455 Age denotes ≥65 years
p1_all12 1583-1587 Outcome denotes SARS
p1_all13 1886-1905 Outcome denotes gender distribution
p1_all14 1978-1996 Outcome denotes percentage of male
p1_all15 2088-2112 Outcome denotes gender role in mortality
p2_o17 2088-2112 Mortality denotes gender role in mortality
p2_o18 2149-2166 Mortality denotes Survival analysis
p1_all16 2520-2534 Outcome denotes mortality rate
p2_o22 2520-2534 Mortality denotes mortality rate
p2_p2 2569-2582 Age denotes Older age and
p2_p3 2583-2587 Sex denotes male